Opko Health, Inc. - Net Worth and Insider Trading
Opko Health, Inc. Net Worth
The estimated net worth of Opko Health, Inc. is at least $205 Million dollars as of 2024-12-25. Opko Health, Inc. is the 10% Owner of GeneDx Holdings Corp and owns about 2,646,972 shares of GeneDx Holdings Corp (WGS) stock worth over $205 Million. Opko Health, Inc. is the 10% Owner of Sorrento Therapeutics Inc and owns about 2,173,859 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $1,522. Opko Health, Inc. is also the 10% Owner of VBI Vaccines Inc and owns about 222,625 shares of VBI Vaccines Inc (VBIVQ) stock worth over $111. Details can be seen in Opko Health, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Opko Health, Inc. has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Opko Health, Inc.
Opko Health, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Opko Health, Inc. owns 6 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) , VBI Vaccines Inc (VBIVQ) , and Cocrystal Pharma Inc (COCP) among others .
Click here to see the complete history of Opko Health, Inc.’s form 4 insider trades.
Insider Ownership Summary of Opko Health, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals Inc | 2017-07-28 | 10 percent owner |
| VBIVQ | VBI Vaccines Inc | 2017-10-30 | 10 percent owner |
| COCP | Cocrystal Pharma Inc | 2014-03-17 | 10 percent owner |
 | | 2013-11-22 | 10 percent owner |
| | 2013-03-12 | 10 percent owner |
| | 2024-08-19 | 10 percent owner |
Opko Health, Inc. Latest Holdings Summary
Opko Health, Inc. currently owns a total of 3 stocks. Among these stocks, Opko Health, Inc. owns 2,646,972 shares of GeneDx Holdings Corp (WGS) as of August 19, 2024, with a value of $205 Million and a weighting of 100%. Opko Health, Inc. owns 2,173,859 shares of Sorrento Therapeutics Inc (SRNE) as of November 22, 2013, with a value of $1,522 and a weighting of 0%. Opko Health, Inc. also owns 222,625 shares of VBI Vaccines Inc (VBIVQ) as of October 30, 2017, with a value of $111 and a weighting of 0%.
Latest Holdings of Opko Health, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2024-08-19 | 2,646,972 | 77.40 | 204,875,633 |
| SRNE | Sorrento Therapeutics Inc | 2013-11-22 | 2,173,859 | 0.00 | 1,522 |
| VBIVQ | VBI Vaccines Inc | 2017-10-30 | 222,625 | 0.00 | 111 |
Holding Weightings of Opko Health, Inc.
Opko Health, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 11 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 1 buys and 10 sells. The most-recent trade in GeneDx Holdings Corp is the sale of 139,824 shares on August 19, 2024, which brought Opko Health, Inc. around $5 Million.
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the sale of 8,471 shares on November 22, 2013, which brought Opko Health, Inc. around $72,004.
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 0 transactions in VBI Vaccines Inc (VBIVQ) over the past 5 years. The most-recent trade in VBI Vaccines Inc is the acquisition of 21,858 shares on October 30, 2017, which cost Opko Health, Inc. around $2 Million.
Insider Trading History of Opko Health, Inc.
- 1
Opko Health, Inc. Trading Performance
GuruFocus tracks the stock performance after each of Opko Health, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Opko Health, Inc. is -4.5%. GuruFocus also compares Opko Health, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Opko Health, Inc. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Opko Health, Inc.'s insider trading performs compared to the benchmark.
Performance of Opko Health, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.74 | | | | | |
| Relative Return to S&P 500(%) | 38.4 | | | | | |
Opko Health, Inc. Ownership Network
Opko Health, Inc. Owned Company Details
What does Eloxx Pharmaceuticals Inc do?
Who are the key executives at Eloxx Pharmaceuticals Inc?
Opko Health, Inc. is the 10 percent owner of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include director & PRESIDENT AND CEO Sumit Aggarwal , HEAD OF R&D Vijay Modur , and Chief Financial Officer Daniel E. Geffken .
Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eloxx Pharmaceuticals Inc Insider Transactions
Opko Health, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Opko Health, Inc.. You might contact Opko Health, Inc. via mailing address: 4400 Biscayne Blvd., Miami Fl 33137.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
